Frequency of the phosphatidylinositol3-kinase, catalytic, α-polypeptide gene amplification in ovarian cancer among Sudanese women: a cross-sectional study

Author:

Elmassry Rawia EljailiORCID,Shrif Nassr Eldin M.A.,Mohammed Aisha OsmanORCID,Elaagip Arwa,Husain Nazik Elmalaika

Abstract

Background: Phosphatidylinositol3-kinase, catalytic, α-polypeptide (PIK3CA) gene is frequently amplified in ovarian carcinoma (OC). To the best of our knowledge, there is a dearth of published reports about the amplification of the PIK3CA gene among Sudanese women with OC. This study aimed to detect the amplification of the PIK3CA gene and its relationship with clinicopathological variables among Sudanese women with OC. Methods: This cross-sectional study included 90 ovarian cases: 83 cases of women diagnosed with OC at Omdurman Maternity Hospital in the period 2013-2018; 7 cases of women with normal ovarian tissues were used as a control to normalize the results. Formalin-fixed paraffin-embedded tissue sections (FFPE) were used to extract RNA at the Institute of Endemic Diseases, Sudan. PIK3CA gene amplification was assessed using quantitative real-time PCR. Results: Amplification of PIK3CA was observed in 33.7% (n = 28/83) of women, with a high frequency in women with clear cell (66.7%; n = 4/6), undifferentiated (50.0%; n = 1/2), serous (35.5%; n = 11/31), mucinous (33.3%; n = 4/12),other (30.8%; n = 4/13), and endometrioid (21.1%; n = 4/19) carcinomas. High frequency was seen in women with higher (39.5%; n = 17/43) rather than in lower grade carcinomas (27.5%; n = 11/40), and in older (43.4%; n = 11/32) rather than younger (30.0%; n = 12/40) women. No significant association between PIK3CA amplification and tumor histologic type, grade, and age of women was observed (Fisher’s Exact test: p = 0.660, 0.698 and 0.687, respectively). Conclusion: PIK3CA gene amplification occurs in about one third of Sudanese women with OC, more frequently in high tumor grades and older women, but not to a statistically significant level. These findings support previous studies suggesting that oncogenic PIK3CA has an essential role in OC progression and may offer a strategy for exact targeted therapy and prognostic evaluation

Publisher

F1000 Research Ltd

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3